Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$469.0M
23M shares
52-week range
$11.01 – $22.79
90% from low
Sector
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Exchange
NASDAQ
CS
Borrow rate
0.44%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $119.7M | $128.0M | $133.3M | $148.0M | $151.6M | $148.6M | $143.1M | $137.4M |
| Cost of revenue | $47.6M | $46.4M | $49.2M | $52.4M | $57.0M | $56.0M | $56.9M | $60.0M |
| Gross profit | $72.1M | $81.5M | $84.1M | $95.6M | $94.5M | $92.6M | $86.1M | $77.4M |
| Gross margin | 60.2% | 63.7% | 63.1% | 64.6% | 62.4% | 62.3% | 60.2% | 56.3% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $35.3M | $43.0M | $42.7M | $50.3M | $46.5M | $40.0M | $35.2M | $22.6M |
| EBITDA | $41.7M | $48.6M | $50.8M | $56.7M | $49.3M | $46.0M | $41.3M | $30.2M |
| Net income | $30.0M | $32.4M | $37.3M | $37.5M | $31.8M | $31.0M | $24.8M | $11.6M |
| Net margin | 25.1% | 25.3% | 28.0% | 25.3% | 21.0% | 20.8% | 17.3% | 8.4% |
| EPS (diluted) | 1.07 | 1.26 | 1.45 | 1.46 | 1.27 | 1.25 | 1.04 | 0.52 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $118M | $0.88 | $0.88–$0.88 | 1 |
| 2027 | $127M | $1.11 | $1.11–$1.11 | 1 |
| 2028 | $129M | $1.16 | $1.16–$1.16 | 1 |
Forward consensus · source: Financial Modeling Prep
NRC Health operates as a humanized healthcare and support organization. Its platform includes Listen, Understand, and Improve. The group provides solutions for Patient, Consumer, Employee, and Market experiences. The group's commitment to Human Understanding helps healthcare systems get to know the patients, families, consumers, employees, and communities it on a human level.
www.nrchealth.comNo one on the platform currently holds NRC.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 340,784 | $5.8M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-26 | $0.1600 | 2026-07-10 |
| 2026-03-27 | $0.1600 | 2026-04-10 |
| 2025-12-26 | $0.1600 | 2026-01-09 |
| 2025-09-26 | $0.1200 | 2025-10-10 |
| 2025-06-27 | $0.1200 | 2025-07-11 |
| 2025-03-28 | $0.1200 | 2025-04-11 |
| 2024-12-27 | $0.1200 | 2025-01-10 |
| 2024-09-27 | $0.1200 | 2024-10-11 |
| 2024-06-28 | $0.1200 | 2024-07-15 |
| 2024-03-27 | $0.1200 | 2024-04-15 |
No one on the platform has traded NRC yet.
| $417M |
| — |
| QTRXQuanterix Corporation | $4.54 | +5.09% | $214M | — |
| SNWVSANUWAVE Health Inc. | $9.85 | +14.40% | $85M | — |
Source: Financial Modeling Prep · peers by sector/industry
| 2023-12-28 |
| $0.1200 |
| 2024-01-12 |
| 2023-09-28 | $0.1200 | 2023-10-13 |
Trading at 21.0× earnings vs its 29.7× historical median P/E.
Fair value ≈ $30.62 · price $21.64 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$NRC great opportunity to get in before the rise continues….
View on StockTwits ↗$NRC details its new ambient listening AI for leader rounding.
View on StockTwits ↗$NRC Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.14 down -44.00% YoY • Reported revenue of $34.8M up 3.73% YoY
View on StockTwits ↗$NRC Share Price: $17.38 Contract Selected: Sep 18, 2026 $15 Calls Buy Zone: $2.89 – $3.57 Target Zone: $5.40 – $6.60 Potential Upside: 76% ROI Time to Expiration: 148 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗$NRC changed its corporate name to NRC Health while keeping its Nasdaq ticker unchanged.
View on StockTwits ↗$NRC I’m watching guidance and management tone next
View on StockTwits ↗$NRC Share Price: $13.44 Contract Selected: Sep 18, 2026 $15 Calls Buy Zone: $0.98 – $1.21 Target Zone: $1.67 – $2.04 Potential Upside: 61% ROI Time to Expiration: 202 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗$NRC Current Stock Price: $13.40 Contracts to trade: $12.5 NRC Mar 20 2026 Call Entry: $0.64 Exit: $0.85 ROI: 33% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗Current Report: National Research Corp $NRC https://talkmarkets.com/article/current-report-national-research-corp-1772034896
View on StockTwits ↗$NRC National Research Corp provides healthcare survey and analytics, facing steady but modest growth with government contract exposure [citation:historical].
View on StockTwits ↗$NRC National Research Corp; healthcare survey and analytics; steady, modest growth; D.C. exposure.
View on StockTwits ↗$NRC just got crushed — stock down 27% after ugly Q4 results ⚠️📉 Q4 EPS and revenues fell year over year due to high prior client attrition, even as recurring contract value grew 8% and points to potential recovery prospects in 2026. Is this a falling knife or an early turnaround setup? Full breakdown here 👉 https://www.zacks.com/stock/news/2842202/nrcs-q4-earnings-down-yy-on-high-client-attrition-stock-falls-27?cid=sm-stocktwits-2-2842202-teaser-32680&ADID=SYND_STOCKTWITS_TWEET_2_2842202_TEASER_32680
View on StockTwits ↗$NRC down 22% in a month — what's dragging it down? 📉 🔻 Q4 EPS fell to 16 cents from 29 cents compared to the prior-year period 📉 Q4 revenue dipped 5% with high client attrition in late 2024 ⚠️ Q4 GAAP net income plummeted to $1.8M from $6.6M compared to the prior-year period But there's a silver lining: TRCV grew 8% Q4 YoY, hinting at a potential recovery. See the full analysis here 👉 https://www.zacks.com/stock/news/2842202/nrcs-q4-earnings-down-yy-on-high-client-attrition-stock-falls-27?cid=sm-stocktwits-2-2842202-body-32677&ADID=SYND_STOCKTWITS_TWEET_2_2842202_BODY_32677
View on StockTwits ↗$NRC Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.08 down -71.43% YoY • Reported revenue of $35.19M down -4.64% YoY
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.